Cargando…
Characteristics of Patients for Whom Benznidazole Was Released Through the CDC-Sponsored Investigational New Drug Program for Treatment of Chagas Disease — United States, 2011–2018
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6065209/ https://www.ncbi.nlm.nih.gov/pubmed/30048425 http://dx.doi.org/10.15585/mmwr.mm6729a3 |
_version_ | 1783342818837659648 |
---|---|
author | Herwaldt, Barbara L. Dougherty, Cindy P. Allen, Christopher K. Jolly, Julian P. Brown, Megan N. Yu, Patricia Yu, Yon |
author_facet | Herwaldt, Barbara L. Dougherty, Cindy P. Allen, Christopher K. Jolly, Julian P. Brown, Megan N. Yu, Patricia Yu, Yon |
author_sort | Herwaldt, Barbara L. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6065209 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Centers for Disease Control and Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-60652092018-08-09 Characteristics of Patients for Whom Benznidazole Was Released Through the CDC-Sponsored Investigational New Drug Program for Treatment of Chagas Disease — United States, 2011–2018 Herwaldt, Barbara L. Dougherty, Cindy P. Allen, Christopher K. Jolly, Julian P. Brown, Megan N. Yu, Patricia Yu, Yon MMWR Morb Mortal Wkly Rep Full Report Centers for Disease Control and Prevention 2018-07-27 /pmc/articles/PMC6065209/ /pubmed/30048425 http://dx.doi.org/10.15585/mmwr.mm6729a3 Text en https://creativecommons.org/licenses/by/3.0/All material in the MMWR Series is in the public domain and may be used and reprinted without permission; citation as to source, however, is appreciated. |
spellingShingle | Full Report Herwaldt, Barbara L. Dougherty, Cindy P. Allen, Christopher K. Jolly, Julian P. Brown, Megan N. Yu, Patricia Yu, Yon Characteristics of Patients for Whom Benznidazole Was Released Through the CDC-Sponsored Investigational New Drug Program for Treatment of Chagas Disease — United States, 2011–2018 |
title | Characteristics of Patients for Whom Benznidazole Was Released Through the CDC-Sponsored Investigational New Drug Program for Treatment of Chagas Disease — United States, 2011–2018 |
title_full | Characteristics of Patients for Whom Benznidazole Was Released Through the CDC-Sponsored Investigational New Drug Program for Treatment of Chagas Disease — United States, 2011–2018 |
title_fullStr | Characteristics of Patients for Whom Benznidazole Was Released Through the CDC-Sponsored Investigational New Drug Program for Treatment of Chagas Disease — United States, 2011–2018 |
title_full_unstemmed | Characteristics of Patients for Whom Benznidazole Was Released Through the CDC-Sponsored Investigational New Drug Program for Treatment of Chagas Disease — United States, 2011–2018 |
title_short | Characteristics of Patients for Whom Benznidazole Was Released Through the CDC-Sponsored Investigational New Drug Program for Treatment of Chagas Disease — United States, 2011–2018 |
title_sort | characteristics of patients for whom benznidazole was released through the cdc-sponsored investigational new drug program for treatment of chagas disease — united states, 2011–2018 |
topic | Full Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6065209/ https://www.ncbi.nlm.nih.gov/pubmed/30048425 http://dx.doi.org/10.15585/mmwr.mm6729a3 |
work_keys_str_mv | AT herwaldtbarbaral characteristicsofpatientsforwhombenznidazolewasreleasedthroughthecdcsponsoredinvestigationalnewdrugprogramfortreatmentofchagasdiseaseunitedstates20112018 AT doughertycindyp characteristicsofpatientsforwhombenznidazolewasreleasedthroughthecdcsponsoredinvestigationalnewdrugprogramfortreatmentofchagasdiseaseunitedstates20112018 AT allenchristopherk characteristicsofpatientsforwhombenznidazolewasreleasedthroughthecdcsponsoredinvestigationalnewdrugprogramfortreatmentofchagasdiseaseunitedstates20112018 AT jollyjulianp characteristicsofpatientsforwhombenznidazolewasreleasedthroughthecdcsponsoredinvestigationalnewdrugprogramfortreatmentofchagasdiseaseunitedstates20112018 AT brownmegann characteristicsofpatientsforwhombenznidazolewasreleasedthroughthecdcsponsoredinvestigationalnewdrugprogramfortreatmentofchagasdiseaseunitedstates20112018 AT yupatricia characteristicsofpatientsforwhombenznidazolewasreleasedthroughthecdcsponsoredinvestigationalnewdrugprogramfortreatmentofchagasdiseaseunitedstates20112018 AT yuyon characteristicsofpatientsforwhombenznidazolewasreleasedthroughthecdcsponsoredinvestigationalnewdrugprogramfortreatmentofchagasdiseaseunitedstates20112018 |